Rhythm Pharmaceuticals, Inc. RYTM NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

49/100

2/7 Pass

SharesGrow Intrinsic Value

Rhythm Pharmaceuticals, Inc. (RYTM) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 RA CAPITAL MANAGEMENT, LLC 5,422,312 주 보유. 기타 주요 보유자에는 RA CAPITAL MANAGEMENT, L.P. 및 THIRD ROCK VENTURES LP.

지난 12개월간 내부자는 57 건의 거래를 수행 RYTM 주식 — 19 건 매수 (평가액 $3.32M) 및 11 건 매도 (평가액 $2.56M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

RYTM 내부자 보유 현황

최대 보유자

RA CAPITAL MANAGEMENT, LLC

5,422,312 주

매수 (12개월)

$3.32M 평가액

매도 (12개월)

$2.56M 평가액

12개월 거래 활동

매수 33%

매도 19%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Ra Capital Management, Llc	10 Percent Owner	5,422,312	2019-10-18	100%
2	Ra Capital Management, L.p.	Officer	4,568,464	2020-12-04	84%
3	Third Rock Ventures Lp	10 Percent Owner	2,981,437	2018-09-04	55%
4	Orbimed Advisors Llc	10 Percent Owner	2,750,079	2018-05-24	51%
5	Foley Todd	Director	909,258	2021-03-16	17%
6	Gottesdiener Keith Michael	CEO & President	207,877	2020-03-11	4%
7	Smith Hunter C	Chief Financial Officer	91,401	2026-03-02	2%
8	Meeker David P	President and CEO	71,900	2026-02-13	1%
9	Desikan Nithya	Chief Commercial Officer	43,602	2020-09-01	1%
10	Fiedorek Fred T.	Chief Medical Officer	25,000	2018-02-16	0%
11	Lee Jennifer Kayden	EVP, Head of North America	21,650	2026-02-13	0%
12	Garfield Alastair	Chief Scientific Officer	16,650	2026-02-13	0%
13	Shulman Joseph	Chief Technical Officer	15,000	2026-02-13	0%
14	Mathers Edward T	Director	14,168	2026-03-16	0%
15	Van Der Ploeg Leonardus H.t.	Chief Scientific Officer	13,611	2019-06-03	0%
16	Manning Linda Shapiro	Chief Medical Officer	12,500	2022-02-11	0%
17	Cramer Pamela J.	Chief Human Resources Officer	11,650	2026-02-13	0%
18	Exter Neil	Director	10,000	2018-06-08	0%
19	Stewart Murray	Chief Medical Officer	9,375	2021-02-16	0%
20	Popovits Kimberly J	Director	6,808	2026-04-03	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-04-01	Mazabraud Yann	EVP, Head of International	옵션 행사 (매도)	2,500	-	-
2026-04-01	Popovits Kimberly J	Director	RSU 부여	6,808	-	-
2026-04-01	Popovits Kimberly J	Director	알 수 없음	-	-	-
2026-03-12	Mathers Edward T	Director	기타 (매수)	4,199	-	-
2026-03-04	German Christopher Paul	Corporate Controller & CAO	정보 매도	5,614	$89.56	$502.79K
2026-03-02	Mazabraud Yann	EVP, Head of International	RSU 부여	35,000	$94.94	$3.32M
2026-03-02	Mathers Edward T	Director	기타 (매수)	4,198	-	-
2026-03-01	German Christopher Paul	Corporate Controller & CAO	옵션 행사 (매도)	1,162	-	-
2026-03-02	Smith Hunter C	Chief Financial Officer	옵션 행사 (매도)	6,099	$6.80	$41.47K
2026-02-19	Smith Hunter C	Chief Financial Officer	정보 매도	585	$103.28	$60.42K
2026-02-17	Smith Hunter C	Chief Financial Officer	정보 매도	200	$103.84	$20.77K
2026-02-14	Mazabraud Yann	EVP, Head of International	옵션 행사 (매도)	10,000	-	-
2026-02-11	Garfield Alastair	Chief Scientific Officer	RSU 부여	16,650	-	-
2026-02-11	Shulman Joseph	Chief Technical Officer	RSU 부여	15,000	-	-
2026-02-11	Cramer Pamela J.	Chief Human Resources Officer	RSU 부여	11,650	-	-
2026-02-11	Lee Jennifer Kayden	EVP, Head of North America	RSU 부여	21,650	-	-
2026-02-11	Mazabraud Yann	EVP, Head of International	RSU 부여	23,350	-	-
2026-02-11	Meeker David P	President and CEO	RSU 부여	71,900	-	-
2026-02-11	German Christopher Paul	Corporate Controller & CAO	RSU 부여	5,215	-	-
2026-02-12	Smith Hunter C	Chief Financial Officer	정보 매도	100	$100.10	$10.01K
2026-02-11	Smith Hunter C	Chief Financial Officer	RSU 부여	25,000	-	-
2026-02-10	Smith Hunter C	Chief Financial Officer	정보 매도	100	$104.76	$10.48K
2026-02-05	Smith Hunter C	Chief Financial Officer	정보 매도	3,381	$106.06	$358.6K
2026-02-04	Smith Hunter C	Chief Financial Officer	정보 매도	747	$107.67	$80.43K
2026-02-01	Garfield Alastair	Chief Scientific Officer	RSU 원천징수	2,026	$108.99	$220.81K